Avisi Technologies has released positive 12-month clinical data on the VisiPlate Aqueous Shunt from the VITA Trial. The VITA ...
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your ...
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your ...
Topline results that were recently released from Sydnexis’s phase 3 Study of Atropine for the Reduction of Myopia Progression ...
The SOL-R registrational trial (NCT06495918) of OTX-TKI (AXPAXLI) by Ocular Therapeutix has reached its randomization target of 555 patients.
AAVantgarde Bio has announced the successful closing of a $141 million (€122 million) Series B financing round that was co-led by a new lead, Schroders Capital, as well as existing investors Atlas ...
Viridian seeks Priority Review for veligrotug, aiming for a potential mid-2026 commercial launch if approved. Global phase 3 ...
Ellen Koo, MD, is associate professor of clinical ophthalmology, and director, Bascom Palmer Palm Beach Gardens and cornea and external diseases fellowship program with the Bascom Palmer Eye Institute ...
Ella Faktorovich, MD, is director of Refractive and Corneal Surgery at Pacific Vision Institute in San Francisco, California. Ophthalmologists discuss topography-guided techniques, long-term corneal ...
Marguerite B. McDonald, MD, FACS, reflects on a first-year residency case that taught her the importance of trusting her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback